MIC Capital Management UK LLP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1889830 LONDON, X0

Position in LYEL

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,745,781

-$932,940 QoQ

Shares Held

87,028

0.0% QoQ

Ownership

0.373%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIC Capital Management UK LLP holds $108,737,992 across 3 Biotechnology names. LYEL ranks #3 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	795,733	$77,385,034
2	RXRX	Recursion Pharmaceuticals, Inc.	9,644,032	$29,607,177
3	LYEL	Lyell Immunopharma, Inc. This page	87,028	$1,745,781

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,745,781	87,028	0.0%	Shares	Sole	2026-05-13
2025-12-31	$2,678,721	87,028	0.0%	Shares	Sole	2026-02-17
2025-09-30	$1,413,334	87,028	0.0%	Shares	Sole	2025-11-14
2025-06-30	$769,327	87,028	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.